Skip to Content
Morningstar
Get 14 Days Free

Amazon.com Inc AMZN

Morningstar Rating
Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Stewardship

PREMIUM

Adoption Will Take Time, but Amazon Pharmacy Unlocks Several New Growth Opportunities

R.J. Hottovy, CFA Sector Strategist

Analyst Note

| R.J. Hottovy, CFA |

The announcement of Amazon Pharmacy (a two-day prescription delivery plan available to all Prime members in 45 states) and the Amazon prescription savings benefit to Prime members should not come as a surprise, as they represent the logical next step in wide-moat Amazon's broader healthcare category. The move follows the 2018 acquisition of PillPack (which will remain a stand-alone service for customers managing multiple daily medications), Haven Healthcare (the employee healthcare partnership between Amazon, Berkshire Hathaway, and JPMorgan Chase), and Amazon Halo (a healthcare monitoring system) and should make Amazon a more significant healthcare player over time. We're not planning to change our five-year assumptions (22% average annual top-line growth, operating margins between 9% and 10%) or our $3,600 fair value estimate based on this development but see the move as strategically important for several reasons.

Read Full Analysis

Company Profile

Business Description

Amazon is among the world's highest-grossing online retailers, with $281 billion in net sales and approximately $365 billion in estimated physical/digital gross merchandise volume (GMV) in 2019. Online product and digital media sales comprised 50% of net revenue in 2019, followed by commissions, related fulfillment and shipping fees, and other third-party seller services (19%), Amazon Web Services' cloud computing, storage, database, and other offerings (13%), Prime membership fees and other subscription-based services (7%), product sales at Whole Foods and other physical store retail formats (6%), and advertising services and cobranded credit cards (5%). International segments constituted 27% of Amazon's non-AWS sales in 2019, led by Germany, the United Kingdom, and Japan.

Contact
410 Terry Avenue North
Seattle, WA, 98109-5210
T +1 206 266-1000
Sector Consumer Cyclical
Industry Internet Retail
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2020
Stock Type Cyclical
Employees 798,000

Related

Fund Spy
What Top Fund Managers Are Buying and Selling
Across the board, Morningstar Medalists got defensive in the third quarter.
Jack Shannon
Rekenthaler Report
Tesla Finally Joins the S&P 500
Thereby making the index even more concentrated, high-growth, and volatile.
John Rekenthaler
Stock Strategist
Rocky Road for Roku?
Despite tremendous subscriber growth, there may not be enough leverage in the current business model.
Neil Macker
Market Update
We’ve Seen a Post-Election Small-Value Rally Before
But this one could really end differently.
Dan Lefkovitz
Stock Strategist
What Amazon's Pharmacy Launch Means for CVS and Walgreens
It could bring more competition, but not enough to change our valuations.
Julie Utterback
Stock Analyst Update
Amazon Pharmacy Causes Headline Risk for Walgreens
We're maintaining Walgreens' narrow moat rating and $42 fair value estimate.
Soo Romanoff
Fund Spy
New Ratings Reveal Who's Serious About Sustainability
ESG Commitment Levels help investors find the right strategies and asset managers.
Margaret Giles
Stock Analyst Update
Amazon Pharmacy Unlocks New Growth Opportunities
We believe the company has an opportunity to improve on existing mail-order prescription platforms.
R.J. Hottovy
Market Update
Is Your Portfolio Too Heavy on Technology Stocks?
There are good reasons behind the sector’s growing dominance, but it warrants some caution.
Amy C. Arnott
Commentary
The Week Ahead: Walmart, Home Depot, and Macy’s to Report Earnings
We also expect reports from NVIDIA and Target.
Carole Hodorowicz
Market Update
A Dramatic Reversal in the Market
Those value funds you own that have annoyed you? Take a look now. Many are surging.
Russel Kinnel
US Videos
3 Good Funds Having a Great Year
These Morningstar Medalists' returns are near the top of their respective categories in 2020.
Morningstar
ETF Specialist
Bond ETF Assets Pass $1 Trillion in October
This has been a seminal year for fixed-income ETFs.
Ben Johnson
Our Picks
What Are the FAANG Stocks Really Worth?
We’ve recently updated our fair value estimates on four of the five names.
Susan Dziubinski
The Short Answer
Newsworthy Stocks Aren't Always Great Investments
We examine the value of some popular companies.
Sachin Nagarajan
Commentary
A Blank Check for Electric Vehicles?
What's electrifying the romance between SPACs and cleantech?
Morningstar Canada
Sustainability Matters
Sustainability Matters: Sustainable Equity Funds Turn In Another Strong Quarter
Of ESG index funds, 25 of 26 have outperformed for the year to date.
Jon Hale
Stock Analyst Update
Acceleration Across Amazon's Services Portfolio
The natural question investors might be asking is how much of wide-moat Amazon's recent momentum is tied to pandemic demand and how much reflects structural changes?
R.J. Hottovy
Commentary
Not All Momentum Rallies Are Led by Tech; This One Sure Is
Investors often equate momentum markets with growth and tech stocks--and this year's rally met those qualifications. But that's not always the case.
Gabrielle Dibenedetto
ETF Specialist
3 Funds for an Evolving Market
Is the market overvaluing growth, undervaluing innovation, or getting things right?
Alex Bryan